Holland Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$27.4M Sell
386,511
-17,552
-4% -$1.17M 1.2% 36
2017
Q1
$27.4M Sell
404,063
-251,409
-38% -$17.7M 1.17% 40
2016
Q4
$46.9M Sell
655,472
-26,630
-4% -$1.98M 1.97% 17
2016
Q3
$54M Sell
682,102
-63,882
-9% -$5.19M 2.21% 13
2016
Q2
$62.2M Sell
745,984
-379,327
-34% -$33.7M 2.41% 13
2016
Q1
$103M Sell
1,125,311
-15,543
-1% -$1.4M 2.74% 10
2015
Q4
$115M Sell
1,140,854
-36,956
-3% -$3.85M 2.97% 9
2015
Q3
$116M Sell
1,177,810
-72,048
-6% -$8M 3% 8
2015
Q2
$146M Sell
1,249,858
-172,754
-12% -$18.9M 3.48% 6
2015
Q1
$140M Sell
1,422,612
-52,620
-4% -$5.34M 3.17% 8
2014
Q4
$139M Sell
1,475,232
-96,051
-6% -$9.93M 3.19% 8
2014
Q3
$167M Sell
1,571,283
-9,348
-0.6% -$915K 3.61% 5
2014
Q2
$131M Buy
1,580,631
+255,453
+19% +$19.9M 2.77% 11
2014
Q1
$93.9M Sell
1,325,178
-67,902
-5% -$5.33M 2.03% 21
2013
Q4
$105M Buy
1,393,080
+10,039
+0.7% +$699K 2.16% 15
2013
Q3
$87M Buy
1,383,041
+41,477
+3% +$2.48M 2.02% 21
2013
Q2
$68.8M Buy
+1,341,564
New +$69.9M 1.74% 27

Other funds holding GILD

Holland Capital Management's GILD Position: Q2 2017 in Review

Holland Capital Management reduced its Gilead Sciences (GILD) stake by 4.3% in Q2 2017, selling an estimated $1.17M and leaving 386,511 shares worth $27.4M. The position accounts for 1.2% of the portfolio, ranked #36.

Holland Capital Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $167M in Q3 2014. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Holland Capital Management held 386,511 shares of Gilead Sciences worth $27.4M as of Q2 2017.
  • Holland Capital Management sold 17,552 Gilead Sciences shares in Q2 2017, an estimated $1.17M.
  • Gilead Sciences made up 1.2% of Holland Capital Management's portfolio in Q2 2017, its #36 holding.
  • Holland Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • Holland Capital Management's Gilead Sciences position peaked at $167M in Q3 2014.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.